Research and innovation

BioNTech’s research and development efforts are deeply rooted in science. We are committed to advancing innovative approaches in medicine and developing novel treatment options.

Therapeutic areas

Oncology

At BioNTech, we aim to cover the entire continuum of cancer treatment and explore curative approaches by harnessing the full potential of the human immune system. By developing therapies that span pathways and complementary modalities, we seek to outmaneuver resistance, enhance treatment effectiveness, destroy cancer at the tumor level and prevent it from coming back.

Learn more

Infectious diseases

BioNTech is committed to addressing infectious diseases with innovative vaccines and therapeutics, focusing on diseases with high and/or unmet medical needs.

Learn more

Explore more about R&D at BioNTech

Scientific groundwork

Founded by scientists to translate science into survival for people living with cancer, BioNTech’s breakthroughs in mRNA research set the stage for the first ever approved mRNA medicinal product. We continue to break new ground in optimizing mRNA technology, aiming to enhance immune responses to address cancer, infectious diseases and other serious diseases.

Learn more

Scientific publications

BioNTech is committed to scientific excellence and innovation by sharing key findings across therapeutic areas and modalities in peer-reviewed formats.

Learn more